(Q42643111)

English

Helicobacter pylori eradication does not influence gastroesophageal reflux disease: a prospective, parallel, randomized, open-label, controlled trial

scientific article published on January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Helicobacter pylori eradication does not influence gastroesophageal reflux disease: a prospective, parallel, randomized, open-label, controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

gastroesophageal reflux disease

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

author name string

Lino Rodrigues Jr

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Cintya Miler de Faria

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Stephan Geocze

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Luiz Chehter

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Arquivos de Gastroenterologia

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

56-63

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Patterns of Gastroesophageal Reflux in Health and Disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Manometric and pH-metric features in gastro-oesophageal reflux disease patients with and without Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Perceived exertion and heart rate models for estimating metabolic workload in elite British soldiers performing a backpack load-carriage task

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032012000100010

21 January 2018

Identifiers

10.1590/S0004-28032012000100010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42643111&oldid=1964382297"